244 related articles for article (PubMed ID: 28716575)
1. Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification.
Agarwal S; Loder SJ; Breuler C; Li J; Cholok D; Brownley C; Peterson J; Hsieh HH; Drake J; Ranganathan K; Niknafs YS; Xiao W; Li S; Kumar R; Tompkins R; Longaker MT; Davis TA; Yu PB; Mishina Y; Levi B
Mol Ther; 2017 Aug; 25(8):1974-1987. PubMed ID: 28716575
[TBL] [Abstract][Full Text] [Related]
2. BMP Ligand Trap ALK3-Fc Attenuates Osteogenesis and Heterotopic Ossification in Blast-Related Lower Extremity Trauma.
Strong AL; Spreadborough PJ; Dey D; Yang P; Li S; Lee A; Haskins RM; Grimm PD; Kumar R; Bradley MJ; Yu PB; Levi B; Davis TA
Stem Cells Dev; 2021 Jan; 30(2):91-105. PubMed ID: 33256557
[TBL] [Abstract][Full Text] [Related]
3. Activin A does not drive post-traumatic heterotopic ossification.
Hwang C; Pagani CA; Das N; Marini S; Huber AK; Xie L; Jimenez J; Brydges S; Lim WK; Nannuru KC; Murphy AJ; Economides AN; Hatsell SJ; Levi B
Bone; 2020 Sep; 138():115473. PubMed ID: 32553795
[TBL] [Abstract][Full Text] [Related]
4. Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.
Lee HW; Chong DC; Ola R; Dunworth WP; Meadows S; Ka J; Kaartinen VM; Qyang Y; Cleaver O; Bautch VL; Eichmann A; Jin SW
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):657-663. PubMed ID: 28232325
[TBL] [Abstract][Full Text] [Related]
5. NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification.
Barruet E; Morales BM; Cain CJ; Ton AN; Wentworth KL; Chan TV; Moody TA; Haks MC; Ottenhoff TH; Hellman J; Nakamura MC; Hsiao EC
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429363
[TBL] [Abstract][Full Text] [Related]
6. BMP type I receptor inhibition reduces heterotopic [corrected] ossification.
Yu PB; Deng DY; Lai CS; Hong CC; Cuny GD; Bouxsein ML; Hong DW; McManus PM; Katagiri T; Sachidanandan C; Kamiya N; Fukuda T; Mishina Y; Peterson RT; Bloch KD
Nat Med; 2008 Dec; 14(12):1363-9. PubMed ID: 19029982
[TBL] [Abstract][Full Text] [Related]
7. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Hif1α prevents both trauma-induced and genetic heterotopic ossification.
Agarwal S; Loder S; Brownley C; Cholok D; Mangiavini L; Li J; Breuler C; Sung HH; Li S; Ranganathan K; Peterson J; Tompkins R; Herndon D; Xiao W; Jumlongras D; Olsen BR; Davis TA; Mishina Y; Schipani E; Levi B
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E338-47. PubMed ID: 26721400
[TBL] [Abstract][Full Text] [Related]
9. BMP signaling mediated by constitutively active Activin type 1 receptor (ACVR1) results in ectopic bone formation localized to distal extremity joints.
Agarwal S; Loder SJ; Brownley C; Eboda O; Peterson JR; Hayano S; Wu B; Zhao B; Kaartinen V; Wong VC; Mishina Y; Levi B
Dev Biol; 2015 Apr; 400(2):202-9. PubMed ID: 25722188
[TBL] [Abstract][Full Text] [Related]
10. Scleraxis-Lineage Cells Contribute to Ectopic Bone Formation in Muscle and Tendon.
Agarwal S; Loder SJ; Cholok D; Peterson J; Li J; Breuler C; Cameron Brownley R; Hsin Sung H; Chung MT; Kamiya N; Li S; Zhao B; Kaartinen V; Davis TA; Qureshi AT; Schipani E; Mishina Y; Levi B
Stem Cells; 2017 Mar; 35(3):705-710. PubMed ID: 27862618
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification.
Lu G; Tandang-Silvas MR; Dawson AC; Dawson TJ; Groppe JC
Bone; 2018 Jul; 112():71-89. PubMed ID: 29626545
[TBL] [Abstract][Full Text] [Related]
12. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
[TBL] [Abstract][Full Text] [Related]
14. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
[TBL] [Abstract][Full Text] [Related]
15. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call.
Towler OW; Shore EM; Xu M; Bamford A; Anderson I; Pignolo RJ; Kaplan FS
Eur J Med Genet; 2017 Jul; 60(7):399-402. PubMed ID: 28473268
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the potent and selective binding of LDN-212854 to the BMP receptor kinase ALK2.
Williams E; Bullock AN
Bone; 2018 Apr; 109():251-258. PubMed ID: 28918311
[TBL] [Abstract][Full Text] [Related]
17. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.
Hino K; Ikeya M; Horigome K; Matsumoto Y; Ebise H; Nishio M; Sekiguchi K; Shibata M; Nagata S; Matsuda S; Toguchida J
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15438-43. PubMed ID: 26621707
[TBL] [Abstract][Full Text] [Related]
18. Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.
Wang H; Lindborg C; Lounev V; Kim JH; McCarrick-Walmsley R; Xu M; Mangiavini L; Groppe JC; Shore EM; Schipani E; Kaplan FS; Pignolo RJ
J Bone Miner Res; 2016 Sep; 31(9):1652-65. PubMed ID: 27027798
[TBL] [Abstract][Full Text] [Related]
19. Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice.
Kawao N; Yano M; Tamura Y; Okumoto K; Okada K; Kaji H
J Bone Miner Metab; 2016 Sep; 34(5):517-25. PubMed ID: 26204847
[TBL] [Abstract][Full Text] [Related]
20. Hints on transcriptional control of essential players in heterotopic ossification of Fibrodysplasia Ossificans Progressiva.
Ravazzolo R; Cappato S; Bocciardi R
Bone; 2018 Apr; 109():187-191. PubMed ID: 29100956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
